An Efficacy and Safety Trial of Intravenous Zoledronic Acid Twice Yearly in Osteoporotic Children Treated With Glucocorticoids
Clinical trial NCT00799266 · COMPLETED
Trial details
- NCT number
- NCT00799266
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-04
- Primary completion
- 2018-03-05
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.